• A
  • A
  • A
  • ABC
  • ABC
  • ABC
  • А
  • А
  • А
  • А
  • А
Regular version of the site
Language Proficiency
English
Contacts
Phone:
15093
Address: 7 Vavilova Ulitsa, room 305
Timetable
SPIN-RSCI: 9950-6479
ORCID: 0000-0003-1816-8699
ResearcherID: V-8485-2018
Scopus AuthorID: 15021253900
Google Scholar
Office hours
09:30-18:00
Supervisors
A. Tonevitsky
D. Maltseva
Printable version

 

Have you spotted a typo?
Highlight it, click Ctrl+Enter and send us a message. Thank you for your help!
To be used only for spelling or punctuation mistakes.

Andrey Poloznikov

  • Andrey Poloznikov has been at HSE University since 2020.

Education and Degrees

  • 2008

    Candidate of Sciences* (PhD)
    Lomonosov Moscow State University

  • 2005

    Degree in Chemistry
    Lomonosov Moscow State University

* Candidate of Sciences
According to the International Standard Classification of Education (ISCED) 2011, Candidate of Sciences belongs to ISCED level 8 - "doctoral or equivalent", together with PhD, DPhil, D.Lit, D.Sc, LL.D, Doctorate or similar. Candidate of Sciences allows its holders to reach the level of the Associate Professor.

Courses (2021/2022)

Courses (2020/2021)

Molecular Biology (Bachelor’s programme; Faculty of Biology and Biotechnology; 2 year, 1, 2 module)Rus

Publications25


Employment history

2017-2020 National Medical Research Radiological Center, Moscow, Russia

DEPUTY DIRECTOR FOR SCIENCE

Integration of state of the art methods to routine diagnostics: liquid biopsy using droplet PCR for melanoma, lung and thyroid cancers; small panel NGS genomic profiling for breast, ovarian and prostated cancers; comprehensive genomic profiling for lung and breast cancers (first study in Russia, 300 patients has been enrolled).
Development of drug test approach using ex vivo culturing of patient-derived three-dimensional tumor organoids and utilizing this model as a platform for preclinical studies of anticancer drugs and personalized treatment
2016-2018 Bioclinicum SRC, Moscow, Russia

PRINCIPAL SCIENTIST

Work on the development of new approaches for preclinical drug testing.
Developing organ-on-chip technology (liver, brain-blood barrier).
Organ-on-chip devices developing.
2011-2019 Federal Research and Clinical Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

LABORATORY HEAD

Drug monitoring.
Research on the leukemia cells chemotherapy resistance. Proteomics, metabolomics and epigenettics studies.
Hematology diseases diagnostics (porphyrias and Hemoglobinopathies). Neuroblastoma diagnostics.
Developing of novel drugs-inhibitors of Hypoxia inducible factor prolyl hydroxilases (HIF PHD).
2011-2016 Peroxo LLC, Moscow, Russia
PROJECT MANAGER
Optimizing technology of native/transgenic and recombinant tobacco peroxidase isolation, SAR research.
Optimizing technology of native and recombinant horseradish peroxidase isolation.
2008-2012 Biochemmack JSC, Moscow, Russia
PRODUCT MANAGER
Product manager and application specialist for the following product lines: microplate readers, automated ELISA analysers
Microarray genetic tests systems: CGH microarray assays for aneuploidy detection
2007-2008 Cornell University Burke Medical Research Institute, NY, USA
SHORT TERM SCHOLAR
Refolding optimization, isolation and characterization of MICAL – axon guidance protein
2007-2008 Lomonosov Moscow State University Moscow, Russia
JUNIOR SCIENTIST
Recombinant tobacco peroxidase: structure – properties relationship.
Isolation and characterization of recombinant plant peroxidases of different origins

Timetable for today

Full timetable